Kowdley KV, Bowlus CL, Levy C, Akarca U, et al. Elafibranor in primary biliary cholangitis: two-year placebo-controlled outcomes and long-term open-label data from the ELATIVE(R) phase III trial. J Hepatol 2026 Aug 27:S0168-8278(26)02859-X. doi: 10.1016/j.jhep.2026.
PMID: 42660235